30 related articles for article (PubMed ID: 38693904)
1. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
[TBL] [Abstract][Full Text] [Related]
2. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
[TBL] [Abstract][Full Text] [Related]
3. Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.
Luo ML; Gong C; Chen CH; Lee DY; Hu H; Huang P; Yao Y; Guo W; Reinhardt F; Wulf G; Lieberman J; Zhou XZ; Song E; Lu KP
Cancer Res; 2014 Jul; 74(13):3603-16. PubMed ID: 24786790
[TBL] [Abstract][Full Text] [Related]
4. Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer.
Gholamzadeh Khoei S; Saidijam M; Amini R; Jalali A; Najafi R
J Gastrointest Cancer; 2022 Jun; 53(2):299-310. PubMed ID: 33580870
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition.
Luo ML; Zheng F; Chen W; Liang ZM; Chandramouly G; Tan J; Willis NA; Chen CH; Taveira MO; Zhou XZ; Lu KP; Scully R; Wulf GM; Hu H
Cancer Res; 2020 Jul; 80(14):3033-3045. PubMed ID: 32193285
[TBL] [Abstract][Full Text] [Related]
6. Correction: Pin1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
Mol Cancer Ther; 2024 May; 23(5):743. PubMed ID: 38693904
[No Abstract] [Full Text] [Related]
7. Recent advances of Pin1 inhibitors as potential anticancer agents.
Bai Y; Yuan Z; Yuan S; He Z
Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
[TBL] [Abstract][Full Text] [Related]
8. Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.
Chuang HH; Zhen YY; Tsai YC; Chuang CH; Huang MS; Hsiao M; Yang CJ
Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33807199
[TBL] [Abstract][Full Text] [Related]
9. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.
Wu W; Xue X; Chen Y; Zheng N; Wang J
Pharmacol Res; 2022 Oct; 184():106456. PubMed ID: 36116709
[TBL] [Abstract][Full Text] [Related]
10. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?
Lu KP; Suizu F; Zhou XZ; Finn G; Lam P; Wulf G
Mol Carcinog; 2006 Jun; 45(6):397-402. PubMed ID: 16652378
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Hijacking of the PIN1 Signaling Network.
Zannini A; Rustighi A; Campaner E; Del Sal G
Front Oncol; 2019; 9():94. PubMed ID: 30873382
[TBL] [Abstract][Full Text] [Related]
12. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]